Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Trial Shows Jardiance Reduced Cardiovascular Death Risk in People with Type 2 Diabetes, Cardiovascul

americanpharmaceuticacreviewSeptember 13, 2017

Tag: Jardiance , type 2 diabetes , Cardiovascular disease

PharmaSources Customer Service